Aurora Cannabis (ACB) Non-Current Assets (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Non-Current Assets of $148.5 million for Q1 2026, down 43.08% year-over-year from $260.9 million in Q1 2025, and down 43.08% quarter-over-quarter from $260.9 million in Q1 2025.
Aurora Cannabis (ACB) Non-Current Assets (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Non-Current Assets for 9 consecutive years, with $148.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets fell 43.08% year-over-year to $148.5 million; the TTM figure through Mar 2026 stood at $963.8 million (down 12.97% YoY), while the FY2026 annual figure was $148.5 million, down 44.86% from the prior year.
- Non-Current Assets slipped to $148.5 million in Q1 2026 per ACB's latest filing, from $260.9 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $330.2 million in Q1 2023 and bottomed at $148.5 million in Q1 2026.
- Historically, Non-Current Assets has averaged $269.7 million across 5 years, with a median of $277.2 million in 2024.
- Annual changes were most pronounced in 2022 — Non-Current Assets tumbled 83.13% — and 2024, when it slipped 7.39%.
- Aurora Cannabis' Non-Current Assets stood at $266.1 million in 2022, then increased by 24.1% to $330.2 million in 2023, then retreated by 18.97% to $267.5 million in 2024, then decreased by 2.49% to $260.9 million in 2025, then sank by 43.08% to $148.5 million in 2026.
- Business Quant data shows ACB's Non-Current Assets at $148.5 million in Q1 2026, $260.9 million in Q1 2025, and $267.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 2.96 Bn |
| 10 | Aurora Cannabis | 232.22 Mn | 159.91 Mn | 25.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 148.49 Mn |
| Mar 31, 2025 | 260.88 Mn |
| Dec 31, 2024 | 267.55 Mn |
| Sep 30, 2024 | 286.86 Mn |
| Jun 30, 2024 | 292.13 Mn |
| Mar 31, 2024 | 305.80 Mn |
| Mar 31, 2023 | 330.20 Mn |
| Jun 30, 2022 | 266.08 Mn |
| Jun 30, 2021 | 1.58 Bn |
| Jun 30, 2020 | 1.70 Bn |
| Jun 30, 2019 | 3.62 Bn |
| Jun 30, 2018 | 1.29 Bn |